Top

Published in:

01-03-2003 | Original Papers

A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor

Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine,and venlafaxine for the treatment of depression in Norway

Authors: C. François, M. Toumi, A.-M. Aakhus, K. Hansen

Title: A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor
Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine,and venlafaxine for the treatment of depression in Norway
Authors: C. François
M. Toumi
A.-M. Aakhus
K. Hansen
Publication date: 01-03-2003
Publisher: Springer-Verlag
Published in: The European Journal of Health Economics / Issue 1/2003
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-002-0139-0